Health care is changing at a rapid level, and it is amazing what people are doing in research and in advancing the field – trying to make care for patients better. The American Academy of Ophthalmology (AAO) hosted their annual meeting with the overall theme of this year: Innovate
We were there – it makes sense for us to participate in an event were all of ophthalmology meets to obtain new knowledge, strengthen skills, implement new techniques, and explore new tools. In this regard, we consider RetinaLyze a new tool and technique that unquestionably has the potential to advance the field for ophthalmologists.
RetinaLyze is a cloud-based real-time eye screening software, which is able to detect signs of diabetic retinopathy from a photo of the retina – in a matter of seconds. The system is as reliable as human screenings, and is easy to implement and operate. (The article continues below the introduction video).
The number of diagnosed diabetics and pre-diabetics is expected to double over the next 10 years. All these diabetic patients need to be screened for diabetic retinopathy once a year – a job that is carried out by ophthalmologist today. But the increase in diabetics is too high compared to the increase in the number of ophthalmologist, which means that there are simply too few ophthalmologists to screen all these patients.
Our software helps ophthalmologists who want to treat diabetic retinopathy and age-related macular degeneration by reducing time spent on people with no retinal lesions and increasing through-put and profit. By using our system ophthalmologists are able to identify patients who need care and treatment in a swiftly manner and focus their effort and care on these patients.
